This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
China Molybdenum Co (CMCLF): New Buy Recommendation for This Basic Materials Giant
Morgan Stanley analyst maintained a Buy rating on China Molybdenum Co on December 15 and set a price target of HK$23.20. The company’s shares closed yesterday at HK$18.27.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The word on The Street in general, suggests a Strong Buy analyst consensus rating for China Molybdenum Co with a $2.61 average price target, implying a -85.71% downside from current levels. In a report released on December 15, UBS also maintained a Buy rating on the stock with a HK$23.40 price target.
CMCLF market cap is currently HK$408.5B and has a P/E ratio of 18.23.
Read More on CMCLF:
Disclaimer & DisclosureReport an Issue
- China Molybdenum Co Invests in High-Growth Sectors through Boyu Capital Fund
- CMOC Group Limited Announces Board Composition and Committee Roles
- CMOC Group Limited Announces Key Board and Governance Changes at 2025 EGM
- CMOC Group Limited Invests in High-Growth Private Equity Fund
- CMOC Group Enhances Governance with New Committee Rules
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
